SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018839
Filing Date
2023-11-13
Accepted
2023-11-13 16:21:53
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20230930x10q.htm   iXBRL 10-Q 1059995
2 EX-31.1 rzlt-20230930xex31d1.htm EX-31.1 15332
3 EX-32.1 rzlt-20230930xex32d1.htm EX-32.1 7374
  Complete submission text file 0001558370-23-018839.txt   5477180

Data Files

Seq Description Document Type Size
4 EX-101.SCH rzlt-20230930.xsd EX-101.SCH 42244
5 EX-101.CAL rzlt-20230930_cal.xml EX-101.CAL 39271
6 EX-101.DEF rzlt-20230930_def.xml EX-101.DEF 186925
7 EX-101.LAB rzlt-20230930_lab.xml EX-101.LAB 327483
8 EX-101.PRE rzlt-20230930_pre.xml EX-101.PRE 298150
58 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20230930x10q_htm.xml XML 932994
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 231399114
SIC: 2834 Pharmaceutical Preparations